SCHEMBL737431

SCHEMBL737431

COc1ccc(-c2coc3cc(OCCCCCCN4CCNCC4)ccc3c2=O)cc1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.81
PDK1 Q15118 1/20 0.58
PDK2 Q15119 1/20 0.58
ALDH2 P05091 5/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25651979 0.93 HRH3 (0.73) HRH3PDK1PDK2ALDH2
SCHEMBL761573 0.91 HRH3 (0.68) HRH3PDK1PDK2ALDH2
SCHEMBL25225774 0.90 PDK1 (0.72) HRH3PDK1PDK2ALDH2
SCHEMBL20576200 0.84 HRH3 (0.71) HRH3PDK1PDK2ALDH2
SCHEMBL25217032 0.84 PDK1 (0.80) HRH3PDK1PDK2ALDH2
SCHEMBL2106830 0.84 HRH3 (0.71) HRH3PDK1PDK2ALDH2
SCHEMBL25222792 0.84 HRH3 (0.71) HRH3PDK1PDK2ALDH2
SCHEMBL4744391 0.83 HRH3 (0.57) HRH3PDK1PDK2
SCHEMBL20576335 0.83 PDK1 (0.82) HRH3PDK1PDK2ALDH2
SCHEMBL17740870 0.83 HRH3 (0.74) HRH3PDK1PDK2ALDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138350-B2 N′-cyano-N-halogenalkylimidamide derivatives BAYER CROPSCIENCE AG (DE) 2012-03-20 US disclosed
US-8138184-B2 Isoxazole derivatives and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-03-20 US disclosed
US-8138184-B2 Isoxazole derivatives and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-03-20 US disclosed
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives BAYER CROPSCIENCE AG (DE) 2010-02-25 US disclosed
US-20090215768-A1 ISOXAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-08-27 US disclosed
US-20090215768-A1 ISOXAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215768-A1 ISOXAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME TBXA2R, F12, PTH1R HRH3 4/4885PDK1 341/4885PDK2 329/4885
US-20100048646-A1 N'-Cyano-N-Halogenalkylimidamide Derivatives NCLN, NISCH, DDT HRH3 2547/4885PDK1 4109/4885PDK2 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.